...
首页> 外文期刊>BioMed research international >Lentivirus-Mediated siRNA Targeting ER-αInhibits Tumorigenesis and Induces Apoptosis in Hepatocarcinoma Cells
【24h】

Lentivirus-Mediated siRNA Targeting ER-αInhibits Tumorigenesis and Induces Apoptosis in Hepatocarcinoma Cells

机译:慢病毒介导的靶向ER-α的siRNA抑制肿瘤发生并诱导肝癌细胞凋亡。

获取原文

摘要

Background and Objectives. Estrogen receptor-α(ER-α) plays important roles in hepatocarcinogenesis. Recent studies have shown that ER-αcould lead to cell cycle progression or inhibition of apoptosis. To better understand the role of ER-α, RNA interference (RNAi) was used to inhibit ER-αexpression in the human hepatocellular carcinoma (HCC) cells.Methods. Lentivirus-mediated ER-αsmall interfering RNA (siRNA) was transfected into HCC cells Hep3B. ER-αexpression was monitored by real-time polymerase chain reaction (PCR) and western blot. Cell proliferation, apoptosis, and invasion were examined by methyl thiazol tetrazolium (MTT), flow cytometry (FCM), and invasion assay, respectively.Results. ER-αsiRNA efficiently downregulated the expression of ER-αin Hep3B cells at both mRNA and protein levels in a time-dependent manner. ER-αsiRNA also inhibited cell proliferation and reduced cell invasion (compared with other groups,P<0.05, resp.). Furthermore, knockdown of ER-αslowed down the cell population at S phase and increased the rate of apoptosis (P<0.05, resp.).Conclusion. ER-αknockdown suppressed the growth of HCC cells. Thus, ER-αmay play a very important role in carcinogenesis of HCC and its knockdown may offer a new potential gene therapy approach for human liver cancer in the future.
机译:背景和目标。雌激素受体-α(ER-α)在肝癌发生中起重要作用。最近的研究表明,ER-α可能导致细胞周期进程或抑制凋亡。为了更好地了解ER-α的作用,使用RNA干扰(RNAi)抑制人肝细胞癌(HCC)细胞中ER-α的表达。将慢病毒介导的ER-α小干扰RNA(siRNA)转染到HCC细胞Hep3B中。通过实时聚合酶链反应(PCR)和western blot监测ER-α的表达。分别用甲基噻唑四唑(MTT),流式细胞仪(FCM)和侵袭试验检测细胞的增殖,凋亡和侵袭。 ER-αsiRNA以时间依赖性方式有效地下调Hep3B细胞在mRNA和蛋白质水平上的ER-α表达。 ER-αsiRNA还抑制细胞增殖并减少细胞侵袭(与其他组相比,P <0.05,分别)。此外,ER-α的敲低减慢了S期的细胞数量并增加了细胞凋亡率(P <0.05,分别)。 ER-α基因敲低抑制了HCC细胞的生长。因此,ER-α可能在肝癌的发生中起着非常重要的作用,其敲除可能为将来人类肝癌的基因治疗提供新的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号